Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

HSA Approval

MOXICLAV 625 TABLET

Approval Number

SIN10689P

Drug Name

MOXICLAV 625 TABLET

Product Name

MOXICLAV 625 TABLET

Approval Date

January 20, 1999

Registrant

MEDOCHEMIE SINGAPORE PTE. LTD.

Licence Holder

MEDOCHEMIE SINGAPORE PTE. LTD.

Regulatory Information

Registrant

MEDOCHEMIE SINGAPORE PTE. LTD.

Licence Holder

MEDOCHEMIE SINGAPORE PTE. LTD.

Drug Type

Therapeutic

Forensic Classification

Prescription Only

Formulation Information

Dosage Form

TABLET, FILM COATED

Route of Administration

ORAL

Medical Information

ATC Code

J01CR02

ATC Item Name

amoxicillin and beta-lactamase inhibitor

Manufacturer Information

Pharmaceutical Manufacturer

MEDOCHEMIE SINGAPORE PTE. LTD.

Manufacturers

Medochemie Ltd – Factory B

Active Ingredients

Ingredient Name

CLAVULANATE POTASSIUM + MICROCRYSTALLINE CELLULOSE EQV TO CLAVULANIC ACID

Strength

125 mg

Drug MonographClavulanic acid

Ingredient Name

AMOXYCILLIN TRIHYDRATE EQV AMOXYCILLIN

Strength

500 mg

Drug MonographAmoxicillin

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy